WO2004009839A2 - Obligonukleotide zum nachweis von mikroorganismen - Google Patents
Obligonukleotide zum nachweis von mikroorganismen Download PDFInfo
- Publication number
- WO2004009839A2 WO2004009839A2 PCT/EP2003/007717 EP0307717W WO2004009839A2 WO 2004009839 A2 WO2004009839 A2 WO 2004009839A2 EP 0307717 W EP0307717 W EP 0307717W WO 2004009839 A2 WO2004009839 A2 WO 2004009839A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oligonucleotides
- oligonucleotide
- under
- iii
- microorganisms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Definitions
- the invention relates to oligonucleotides for the detection of microorganisms, a method for the detection of the microorganisms and a kit for carrying out this method.
- microorganisms The detection of microorganisms is still predominantly carried out serologically or microscopically.
- the methods are not sensitive enough to directly detect small amounts of microorganisms. For this reason, a cultivation step in which the microorganisms were propagated has been carried out up to now.
- a disadvantage of this method is that some of the microorganisms do not grow on the available nutrient media and therefore cannot be detected.
- Studies on various environmental samples show that e.g. Currently only between 0.1 to 14% of all bacteria can be cultivated. Cultivation-dependent methods have proven to be unsuitable, in particular for analyzing the composition of a complex biocenosis.
- hybridization means in particular the formation of a double helix from two single-stranded, complementary oligo- or polynucleotides. Hybridization can in particular arise between two DNA or two RNA molecules, but also between DNA and RNA molecules. The different molecules hybridize only if the target sequences are sufficiently complementary to one another.
- the complementary target sequences for the detection can also be immobilized, as is often done on so-called DNA chips.
- a carrier DNA chip
- Oligonucleotides which are complementary to known reference sequences of certain bacteria or viruses which occur in the oral flora are immobilized on this support. Due to the complementarity, the oligonucleotides applied to this gene chip can hybridize with the corresponding reference sequences under certain conditions.
- a disadvantage of this carrier is that the microorganisms either have to be propagated by cultivation or the genetic information from the samples present has to be amplified on the chip before hybridization. It is therefore also not possible to quantify the microorganisms originally present in a sample.
- PCR polymerase chain reaction
- a characteristic piece of the respective microorganism quantity is amplified with specific primers. If the primer finds its destination, a piece of the genetic material multiplies millions of times.
- a qualitative assessment can take place. In the simplest case, this leads to the statement that the target points for the used primers were present in the sample examined. No further statements are possible; these target sites can originate from a living bacterium as well as from a dead bacterium or from naked DNA. A differentiation is not possible here.
- Various substances present in the examined sample can also inhibit the DNA-amplifying enzyme, the Taq polymerase.
- PCR technique quantitative PCR, in which an attempt is made to establish a correlation between the amount of microorganisms present and the amount of amplified DNA.
- the advantages of PCR are its high specificity and the short time it takes.
- Significant disadvantages are their high susceptibility to contamination and the false positive results they cause, as well as the aforementioned lack of ability to differentiate between living and dead cells or naked DNA, and finally the risk of false negative results due to the presence of inhibitory substances.
- FISH fluorescence in situ hybridization
- microorganism species, species or groups can be identified in the sample in a highly specific manner and, if necessary, visualized or quantified. This method is the only method that provides a distortion-free representation of the actual in situ conditions of the biocenosis. Even microorganisms that have not yet been cultivated and therefore not described can be identified.
- FISH FISH, probes penetrate the cells in the sample under investigation. If a microorganism of the type, genus or group for which the probes were developed is present in the sample under investigation, the probes in the microorganism cell bind to their target sequence and the cells can be detected on the basis of the labeling of the probes.
- probes can be used to detect numerous microorganisms that traditional cultivation does not detect. While only a maximum of 15% of the bacterial population of a sample can be made visible by cultivation, the FISH technique allows detection of up to 100% of the total bacterial population in many samples. Second, the detection of microorganisms using the FISH technique is much faster than using cultivation. If the identification of microorganisms by cultivation often takes several days, it only takes a few hours from sampling to microorganism identification even at the species level using the FISH technique. Thirdly, in contrast to a cultivation medium, the specificity of probes can be chosen almost arbitrarily. Individual species can be detected with a probe just as easily as entire genera or groups of microorganisms. Fourthly, microorganism types or entire microorganism populations can be precisely quantified directly in the sample. Fifthly, associations and associations of different microorganisms can be visualized in one sample.
- the FISH In contrast to PCR, the FISH reliably detects only living microorganisms. False positive results due to bare DNA or dead microorganisms such as PCR are excluded with the FISH. Furthermore, false negative results due to the presence of inhibitory substances are excluded, as are false positive results due to contamination.
- the FISH technique is therefore an outstanding tool for quickly and extremely specifically detecting microorganisms directly in a sample. In contrast to cultivation methods, it is a direct method and also allows the microorganisms contained in the sample to be quantified.
- the human skin for example, with an area of approximately 2 m 2, is one of the largest human body organs inhabited by microorganisms. In the course of evolution, a close relationship has developed between the host and its microbial inhabitants. The nutrients made available by the skin through various body glands are metabolized by microorganisms. The resulting acidification of the skin surface prevents the settlement of pathogenic microorganisms.
- the metabolic activity of microorganisms can also have undesirable consequences. So is the development of body odor, dandruff and the development of various skin diseases. attributed to the activity of microbes.
- yeast Malassezia is suspected to be particularly involved in the formation of flakes on the skin, for example on the head. This organism is also considered to trigger the skin disease pityriasis versicolor.
- Propionihacterium acnes An increased occurrence of Propionihacterium acnes can indicate the development of acne at an early stage.
- Transient flora microorganisms that cannot multiply on the human skin or are found only irregularly and in small numbers / proportions during examinations. According to the theory, these microorganisms are free and do not adhere to skin components.
- oligonucleotides suitable as nucleic acid probes for other, more widespread microorganisms which can open up new areas of use.
- probes for the detection of such microorganisms that can come into contact with humans and / or animals, e.g. in food, waste water, environmental samples or from the skin surface.
- oligonucleotides for the detection of microorganisms selected from a group consisting of: i) oligonucleotides with the in SEQ ID NO. 01 to 30 specified
- oligonucleotides which differ from one of those mentioned under i) and ii)
- oligonucleotides the sequence being deleted or extended by one or more nucleotides, and iv) oligonucleotides, which have a sequence which belongs to one of the
- Oligonucleotides under i), ii) or iii) is complementary, under stringent
- Hybridize conditions as well as a method for using these oligonucleotides and a kit for applying the method.
- microorganism group is to be understood as meaning at least two types of microorganisms which either belong to the same genus or have a very similar rRNA.
- a microorganism group according to the invention can also contain, for example, all species of a genus.
- oligonucleotides with the in SEQ ID NO. 01 to 30 specified sequences and those oligonucleotides which correspond to these at least in 80%, preferably in at least 84%, particularly preferably in at least 90%, very particularly preferably in 95% of the nucleotides also includes those oligonucleotides which differ from the derive said oligonucleotides, wherein they are extended or deleted by one or more nucleotides.
- oligonucleotides with the in SEQ ID NO. 19 to 30 specified sequences and those oligonucleotides which correspond to these at least in 77%, preferably in at least 83%, particularly preferably in at least 88%, very particularly preferably in 94% of the nucleotides also includes those oligonucleotides which differ from the named ones Derive oligonucleotides, wherein they are extended or deleted by one or more nucleotides.
- 1 to 40 preferably 1 to 25, in particular 1 to 15 nucleotides to be appended to the 3 'and / or 5' end of the oligonucleotides mentioned.
- oligonucleotides which can be derived from the oligonucleotides mentioned in particular by deleting the sequence by 1 to 7, preferably 1 to 5, in particular one to three, for example one or two, nucleotides.
- the microorganisms to be detected are selected from the genera Staphylococcus, Peptostreptococcus, Propionibacterium, Corynebacterium, Veillonella, Malassezia and / or the Sporomusa taxon.
- the microflora of the skin has so far only been investigated using the known cultivation methods. Due to the methodological deficiency already mentioned, only cultivable bacteria or fungi were detected. For example, the following species were found: Staphylococcus aureus, S. epidermidis, S. cohnii, S. haemolyticus, S. hominis, S. capitis, S. warn, S. sciuri, S. schleifen, S. intermedius, Veillonella spec, Propionibacterium acnes , Malassezia sloffiae, M. pachydermatis, M. furfur, Corynebacterium minutissimum, C. amycolatum, C. striatum and C.
- skin is understood to mean human and / or animal skin or mucous membrane and the appendages of the skin (hair, hair follicles, nails, glands).
- the oligonucleotide carries a detectable marker, in particular a fluorescent marker, which is in particular covalently bound to the oligonucleotide.
- a detectable marker in particular a fluorescent marker
- the detectability of the hybridization of the oligonucleotide with the target sequence is a prerequisite for the identification and, if necessary, quantification of the microorganisms. In particular, this is often achieved by covalently binding a detectable marker to the oligonucleotide.
- Fluorescent groups for example Cy-2, Cy-3 or Cy-5 (Amersham Life Sciences, Inc., Arlington Heights, USA), FITC (fluorescein isothiocyanate), CT (5, (6) - carboxytetramethylrhodamine-N.) Are frequently used as detectable markers -hydroxysuccinimide ester (Molecular Probes Inc., Eugene, USA)), TRITC (tetramethylrhodamine-5,6-isothiocyanate (Molecular Probes Inc., see above) or FLUOS (5, (6) -carboxyfluorescein-N-hydroxysuccinimide ester (Boehringer Mannheim, Mannheim , Germany))
- chemiluminescent groups or radioactive labels eg 35S, 32P, 33P, 125J, are used, but detection can also be provided by coupling the oligonucleotide with an enzymatically active molecule, for example alkaline phosphatase, acidic phosphatase,
- Alkaline phosphatase and 4-methylumbelliferyl phosphate (*) acid phosphatase bis (4-methylumbelliferyl phosphate), (*) 3-O-methylfluorescein, flavone-3-disphosphate triammonium salt (*), p-nitrophenylphosphate disodium salt
- Peroxidase tyramine hydrochloride (*), 3- (p-hydroxyphenyl) propionic acid (*), p-hydroxyphenethyl alcohol (*), 2,2'-azino-bis (3-ethylbenzothiazoline sulfonic acid) (ABTS), ortho-phenylenediamine dihydrochloride, o-Dianisidine, 5-aminosalicylic acid, p-Ucresol (*), 3,3'-dimethyloxybenzidine, 3-methyl-2-benzothiazolinehydrazone, tetramethylbenzidine
- oligonucleotides in such a way that a further nucleic acid sequence suitable for hybridization is present at their 5 'or 3' end.
- This nucleic acid sequence in turn comprises approximately 15 to 1,000, preferably 15-50 nucleotides.
- This second nucleic acid region can in turn be recognized by an oligonucleotide which can be detected by one of the means mentioned above.
- Another possibility is to couple the detectable oligonucleotides with a hapten, which can then be brought into contact with an antibody that recognizes the hapten.
- Digoxigenin can be cited as an example of such a hapten. The skilled worker is also well known about the examples given.
- the enzymatic marker is selected from a group consisting of peroxidase, preferably horseradish peroxidase, and phosphatase, preferably alkaline phosphatase.
- Another object of the invention is an oligonucleotide combination for the detection of microorganisms containing at least one, preferably two or more of the said oligonucleotides.
- an oligonucleotide combination is understood to mean a composition which contains at least one or more oligonucleotides, for example in a solution (for example a buffer solution) or a mixture (for example in the lyophilized state).
- a solution for example a buffer solution
- a mixture for example in the lyophilized state.
- the oligonucleotides can also be present separately from one another (e.g. in different vessels), next to one another (for example on a chip or in a kit).
- the oligonucleotide combination i) contains at least one oligonucleotide for the specific detection of bacteria of the genus Staphylococcus selected from the group consisting of a) Oligonucleotides with the in SEQ ID NO.
- Genus Peptostreptococcus selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 04 to 06 and 27 to 29 sequences indicated, and b) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 1 ii) and c) oligonucleotides which match the oligonucleotides under a) according to the details of claim 1 iii ) agree and d) oligonucleotides which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- oligonucleotide for the specific detection of bacteria of the genus Corynebacterium selected from the group consisting of a) Oligonucleotides with the in SEQ ID NO. 07 to 12 and No.
- oligonucleotide for the specific detection of bacteria of the genus Veillonella selected from the group consisting of a) oligonucleotides with the in SEQ ID NO. 13 to 15 specified sequences, and b) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 1 ii) and c) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 1 iii) and d ) Oligonucleotides which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- oligonucleotide for the specific detection of bacteria of the species Propionibacterium acnes selected from the group consisting of a) Oligonucleotides with the in SEQ ID NO. 16 and 17 specified sequences, and b) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 1 ii) and c) oligonucleotides which correspond to the oligonucleotides under a) according to the details of claim 1 iii) and d ) Oligonucleotides which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- Genus Malassezia selected from the group consisting of a) an oligonucleotide with the in SEQ ID NO. 18 specified sequence and b) oligonucleotides which correspond to the oligonucleotide under a) in accordance with the statements of claim 1 ii) and c) oligonucleotides which correspond with the oligonucleotide under a) in accordance with the statements in claim 1 iii) and d) oligonucleotides, which hybridize with a sequence which is complementary to one of the oligonucleotides under a), b) or c) under stringent conditions.
- At least one oligonucleotide for the specific detection of microorganisms from the sporomusa taxon selected from the group consisting of a) an oligonucleotide with the in SEQ ID NO.
- the oligonucleotides according to the invention enable the specific detection of microorganisms of the genera Staphylococcus, Peptostreptococcus, Propionibacterium, Corynebacterium, Veillonella, Malassezia and the Sporomusa taxon.
- oligonucleotides each from one of the groups i), ii), iii), iv), v), vi) or vii) is to be understood here.
- oligonucleotides selected from four groups ie from group i) with ii), iii) and iv) are also to be used; i) with ii), iii) and v); i) with ii), iii) and vi), i) with ii), iii) and vii); i) with ii), iv) and v); i) with ii), iv) and vi); i) with ii), iv) and vi); i) with ii), v) and vi), i) with ii), v) and vii); i) with ii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii); i) with iii), vi) and vii
- the oligonucleotide combination according to the invention is therefore suitable for detecting a microorganism species or a group of microorganisms.
- one or more oligonucleotides according to i) are selected, for example, for the detection of certain species of Staphylococcus.
- the combination of the oligonucleotides (according to the abovementioned Possible combinations) the detection of species and / or groups of microorganisms of the various genera mentioned can be carried out simultaneously and / or next to one another.
- the detection of microorganisms of the genus Staphylococcus can be carried out simultaneously and / or next to one another to detect microorganisms of the species Propionibacterium acnes (by selecting one or more oligonucleotides according to v)) occur.
- the possible combinations can thus be individually adapted to the respective requirements.
- a suitable complementary sequence is present in the microorganism to be detected.
- a sequence is suitable if, on the one hand, it is specific for the microorganism to be detected and, on the other hand, it is accessible at all to the penetrating oligonucleotide, that is, it is not masked by ribosomal proteins or rRNA secondary structures.
- Fuchs and coworkers BM Fuchs, G. Wallner, W. Beisker, I. Schwippl, W. Ludwig, and R. Amann.
- oligonucleotide with good binding behavior is by no means derived from the primary sequence of the rRNA and consequently cannot be found using consensus sequence search programs.
- a type of microorganism, a type of microorganism or a group of microorganisms can be detected.
- Complementarity should exist for an oligonucleotide of 15 nucleotides over 100% of the sequence. For oligonucleotides with more than 15 nucleotides, one or more mismatching sites are allowed.
- oligonucleotides are provided for the specific detection of microorganisms of the genus Staphylococcus, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 01 to 03 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Staphylococcus: S. aureus, S. epidermidis, S. saccharolyticus, S. caprae, S. capitis, S. warn, S. pasteuri, S. arlettae, S. gallinarum, S. cohnii, S. succinus, S. kloosii, S. saprophyticus, S. equorum, S. xylosus, S. haemolyticus, S. hominis, S. lugdunensis, S. chromogenes, S. auricularis, S. schleifen, S. sciuri, S.
- microorganisms with a similar rRNA sequence are not covered by these oligonucleotides: Paenibacillus polymyxa, Bacillus lentus, Bacillus cereus, Bacillus subtilis, Bacillus mycoides, Proteus vulgaris, Burkholderiausocococides, and Bokholderia cepacis.
- Paenibacillus polymyxa Bacillus lentus
- Bacillus cereus Bacillus subtilis
- Bacillus mycoides Proteus vulgaris
- Burkholderiausocococides Burkholderiausocococides
- Bokholderia cepacis Bokholderia cepacis
- the oligonucleotide according to SEQ ID NO. 02 is for the detection of microorganisms of the genus Staphylococcus, in particular of S. intermedius, S. delphini, S. muscae, S. condimenti, S. piscifermentans, S. carnosus, S. grind, S. felis and S. simulans, preferred by S. intermedius and S. grind suitable.
- a combination of the oligonucleotides with those under SEQ ID NO is particularly preferred. 01 to 02 specified sequences. This combination detects at least the following species of the genus Staphylococcus: S. aureus, S. epidermidis, S. caprae, S. capitis, S. warn, S. pasteuri, S. arlettae, S. gallinarum, S. cohnii, S. succinus , S. kloosii, S. saprophyticus, S. equorum, S. xylosus, S. haemolyticus, S. hominis, S. lugdunensis, S. chromogenes, S. auricularis, S.
- oligonucleotides for the specific detection of microorganisms of the genus Peptostreptococcus are also provided, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 04 to 06 and 27 to 29 specified sequences.
- the bacteria known under the generic name "Peptostreptococcus” can be assigned to various subgroups, in particular the genera Anaerococcus, Peptoniphilus or Finegoldia, according to the latest findings.
- Each of the specified oligonucleotides detects at least one of the following species of the genera Anaerococcus, Peptoniphilus or Finegoldia belonging to the generic term "Peptostreptococcus”: P. assaccharolyticus, P. lacrimalis, P. hareii, F. magnus, A. tetradius, A. hydrogenalis, A. lactolyticus, A. octavius, and A. vaginalis.
- oligonucleotides with the under SEQ ID NO. 04 to 06 specified sequences. These oligonucleotides each detect at least the following peptostreptococcal species, in particular those of the genus Anaerococcus: Anaerococcus hydrogenalis, A. lactolyticus, A. octavius, A. prevotii, Anaerococcus tetradius and A. vaginalis.
- the species of the genus Peptostreptococcus mentioned below and other microorganisms with a similar rRNA sequence, but which do not belong to the genus Peptostreptococcus, in particular Anaerococcus, are not covered: Peptoniphilus lacrimalis, Peptostreptococcus anaerobius, Finegoldia magniotus, and Ruminididoccus product, and Ruminidocibus product, as well as Ruminidococcus Clostridium hastiform.
- the oligonucleotide with the one under SEQ ID NO. 04 specified sequence detects at least the following species of the microorganisms falling under the generic term "Peptostreptococcus”: Anaerococcus hydrogenalis, A. lactolyticus, A. octavius, A. prevotii and A. vaginalis.
- oligonucleotides for the specific detection of microorganisms of the genus Peptostreptococcus are also provided, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 27 to 29 sequences indicated.
- the species of the genus Peptostreptococcus mentioned below and other microorganisms with a similar rRNA sequence, but which do not belong to the peptostreptococci, are not recorded; Micromonas micros, Helcococcus kunzii, Helcococcus ovis.
- the oligonucleotides with those under SEQ ID NO. 27 and 28 specified sequences detect at least the following species of the genus Peptoniphilus: Peptoniphilus assaccharolyticus, P. hareii, P. indolicus (in particular the ATCC 29427 strain and those strains which are closely related to it, ie have a very similar rRNA) and P. lacrimalis.
- Pseudomonas saccharophila Variovorax paradoxus
- Finegoldia magna Staphylococcus epidermidis
- Propionibacterium acnes Micromonas micros, Gallicola baranese, Atopobium parvulum, Veilonella dispar and Cseudiesococcus putida, as well as Pseudomonocacterium putida and Pseudomonocacterium putida.
- the oligonucleotide with the under SEQ ID No. 28 specified sequence detects in particular microorganisms of the species Peptoniphilus lacrimalis.
- the oligonucleotide with that under SEQ ID NO. 29 specified sequence.
- This oligonucleotide detects at least the species Finegoldia magna from the microorganisms falling under the generic term "peptostreptococci" and those microorganisms which are very similar in their rRNA sequence, while the following microorganisms cannot be detected at the same time: Anaerococcus hydrogenalis, Peptostreptococcus anaerhilus, Pepton lacrimalis, Staphylococcus epidermidis, Halocella cellulosilytica, Propionibacterium acnes, Micromonas micros, Veillonella dispar, Pseudomonas putida and other species of the genera Anaerococcus, Corynebacterium and Peptoniphilus.
- oligonucleotides for the specific detection of microorganisms of the genus Corynebacterium are also provided, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 07 to 12 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Corynebacterium: C. glutamicum, C. lipophiloflavum, C. glucuronolyticum, C. macginleyi, C. accolens, C. fastidiosum, C. segmentosum, C. ammoniagenes, C. minutissimum, C. flavescens, C. coyleiae, C. afermentans, C. pseudogenitalium, C. genitalium, C. mucofaciens, C. auris, C. mycetoides, C. cystitidis, C. pilosum, C. pseudotuberculosis, C.
- ulcerans C. diphteriae, C. vitarumen, C. carriages, C. genitalium, C. argentoratens, C. callunae, C. bovis, C. variabilis, C. amycolatum, C. "tuberculostearicum", C. xerosis, C. matruchotii, C. jeikeium, C. efficiens, C. thomsenii, C. nigricans, C. auriscanis, C. mooreparkense, C. casei, C. camporealensis, C. sundsvallense, C. mastidis, C. imitans, C. riegelii, C. asperum, C. freneyi, C. striatum, C. coyleiae and C. simulans.
- the oligonucleotide with the one under SEQ ID NO. 10 specified sequence used for the detection of Corynebacteria of the species C. striatum and / or C. xerosis.
- oligonucleotide with the under SEQ ID NO. 11 specified sequence used for the detection of Corynebacteria of the species C. jeikeium.
- a combination of the oligonucleotides with those under SEQ ID NO is particularly preferred. 07, 08, 10 and 11 specified sequences. This combination detects at least the following species of the genus Corynebacterium: C. glutamicum, C. lipophiloflavum, C. glucuronolyticum, C. macginleyi, C. accolens, C. fastidiosum, C. segmentosum, C. ammoniagenes, C. minutissimum, C. flavescens , C. coyleiae, C. afermentans, C. pseudogenitalium, C. "genitalium", C. mucofaciens, C. auris, C. mycetoides, C.
- cystitidis C. pilosum, C. pseudotuberculosis, C. ulcerans, C. diphteriae , C. camporealensis, C. vitarumen, C. kutscheri, C. argentoratens, C. callunae, C. bovis, C. renale, C. riegelii, CC variabilis, C. amycolatum, C. "tuberculostearicum", C. xerosis, C. matruchotii, C. jeikeium.
- oligonucleotides are provided for the specific detection of microorganisms of the genus Corynebacterium, the oligonucleotides being complementary to the rRNA and being selected from a group consisting of oligonucleotides with those under SEQ ID NO. 19 to 26 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Corynebacterium: C. coyleiae, C. afermentans, C. "genitalium”, C. mucifaciens, C. amycolatum, C. “tuberculostearicum” and C. riegelii. These oligonucleotides are suitable for specifically detecting a group from one or more, very closely related species of the genus Corynebacterium.
- microorganisms with a similar rRNA sequence are advantageously not detected by these oligonucleotides:. Clostridium acetobutylicum, Eubacterium yurii and Fusobacterium nucleatum. The following bacteria belonging to the skin microflora are also not recorded: Micrococcus luteus, Micrococcus varians, Micrococcus lyae, Acinetobacter calcoaceticus and Streptococcus pyogenes. This is a particular advantage and shows the high specificity of the probes.
- the oligonucleotide with the one under SEQ ID NO. 19 specified sequence for the detection of a group of microorganisms from the genus Corynebacterium used by C. "tuberculostearicum" (in particular ATCC 35692) or the group around the strain with the designation CDC G5840 (Acc. No. X80498) and such microorganisms is formed, which have a very similar rRNA.
- microorganisms which are very closely related to the microorganism or whose rRNA has a high degree of identity and / or in particular in the section hybridizing with the oligonucleotide mentioned with the rRNA of the said microorganisms completely or almost completely (ie with a deviation of one or more, preferably one to three nucleotides) agree.
- This probe advantageously detects C. "tuberculostearicum” and the species of the genus Corynebacterium that have a very similar rRNA without detecting the following, more closely related species of the genus Corynebacterium: C. minutissimum, C. diphteriae, C. striatum, C. xerosis, C. "fastidiosum", C. camporealensis, C. accolens and C. "pseudogenitalium” as well as C. afermentans, C. jeikeium, C. durum, C. mucifaciens, C. renale, C. riegelii, C. glutamicum, C. lipophiloflavum, C. glucuronolyticum C. ammoniagenes, C. coyleiae, C. pseudotuberculosis, C. kutscheri, C. callunae and C. urealyticum.
- C. amycolatum and species closely related to this species is the probe with the probe under SEQ ID NO. 20 specified sequence used.
- This probe advantageously detects C. amycolatum, and those species of the genus Corynebacterium which have a very similar rRNA and which, in particular in the portion of the rRNA hybridizing with said oligonucleotide, has only a few, preferably no mismatches, without the following, more distant related species of the To detect genus Corynebacterium; C. "asperum", C. jeikeium, C. bovis, C. freneyi, C. afermentans, C. durum, C. matruchotii, C.
- mucifaciens C. renale, C. glutamicum, and C. xerosis and C. lipophiloflavum , C. glucuronolyticum, C. minutissimum, C. ammoniagenes, C. camporealensis, C. coyleiae, C. pseudotuberculosis, C. riegelii, C. kutscheri, C. callunae and C. urealyticum.
- the oligonucleotide with the one under SEQ ID NO. 21 specified sequence for the detection of certain species of microorganisms, in particular the genus Corynebacterium, which with the partial sequence of 16 S rRNA indicated under Seq ID No 31 is used in at least 60%, preferably in at least 70%, particularly preferably in at least 80% and entirely particularly preferably in at least 90%, for example at least 95% of the nucleotides match.
- This probe advantageously detects the specified species of the genus Corynebacterium without detecting the following, more closely related species of the genus Corynebacterium; C. "genitalium", C. mucifaciens, C. coyleiae, C. glucuronolyticum, C.
- the oligonucleotide with the one under SEQ ID NO. 23 specified sequence used for the detection of Corynebacteria of the species C. afermentans.
- This probe advantageously detects C. afermentans and those species of the genus Corynebacterium which have a rRNA very similar to these species without detecting the following, more distant, related species of the genus Corynebacterium; C. "genitalium", C. mucifaciens, C. ammoniagenes, C. coyleiae, C. glucuronolyticum, C. riegelii, C. thomssenii. C. pseudogenitalium and C. lipophiloflavum as well as C. amycolatum, C. jeikeium, C. durum, C. renale, C. striatum, C. glutamicum, C. accolens, C.
- the oligonucleotide with the one under SEQ ID NO. 25 specified sequence used for the detection of Corynebacteria of the species C. afermentans, C. mucifaciens, C. coyleiae and / or "C. genitalium"
- This probe advantageously detects C. afermentans, C. mucifaciens, C. coyleiae and "C. genitalium” as well as those species of the genus Corynebacterium which have an rRNA very similar to these species without detecting the following, more closely related species of the genus Corynebacterium; C. xerosis, C. jeikeium, C. urealyticum, C. amycolatum, C. glutamicum, C. striatum, C. accolens, C. renale, C. ammoniagenes and C. kutscheri and C. glucuronolyticum, C. camporealensis, C. pseudotuberculosis, C. durum, C. minutissimum, C. lipophiloflavum, C. callunae and C. thomssenii.
- This oligonucleotide also does not detect the following microorganisms, which do not belong to the genus Corynebacterium, but have a similar rRNA: Nanomurea fastidiosa, Micromonospora echinospora, Abiotropha elegans and Arcanobacterium pyogenes.
- oligonucleotides for the specific detection of microorganisms of the genus Veillonella are furthermore provided according to the invention, the probes being complementary to the rRNA and being selected from a group consisting of oligonucleotides with the SEQ ID NO. 13 to 15 specified sequences.
- Each of the specified oligonucleotides detects at least one of the following species of the genus Veillonella: V. dispar, V. parvula and V. atypica. Since the genus Veillonella is largely isolated in the phylogenetic family tree, advantageously no detection of non-target organisms is found.
- a combination of the oligonucleotides with those under SEQ ID NO is particularly preferred. 13 to 14 specified sequences. This combination detects at least the following species of the genus Veillonella: V. dispar, V. parvula and V. atypica.
- oligonucleotides for the specific detection of microorganisms of the species Propionibacterium acnes are also provided, the probes being complementary to the rRNA and being selected from a group consisting of oligonucleotides with the SEQ ID NO. 16 to 17 specified sequences. Each of the specified oligonucleotides specifically detects the Propionibacterium acnes species.
- microorganisms with a similar rRNA sequence are not recorded: P. propionicus, P. granulosum, P. avidum, P. freudenreichii, P. thoeni, P. lymphophilus, C. minutissimum, Saccharomonospora viridis, Nocardiodes spec, Propioniferax innocua, Gordonia sputi and Arcanobacterium.
- an oligonucleotide for the specific detection of microorganisms of the genus Malassezia is further provided according to the invention, the oligonucleotide being complementary to the rRNA and that under SEQ ID NO. Has 18 specified sequence.
- the specified oligonucleotide detects at least one of the following species of the genus Malassezia: M. sloffiae, M. pachydermatis, M. furfur.
- the specified oligonucleotide detects at least the species Acidaminococcus fermentans, Phascolarctobacterium faecium and with them closely related microorganisms with very similar rRNA, but not the following microorganisms: Veillonella spec. Halobacillus halophilus, Sporomusa paucivorans, Macrococcus caseolyticus, Anaeromusa acidaminophila, Halocella cellulosilytica, Peptostreptococcus anaerobius, Succiniclasticum ruminis and Succinispira mobilis.
- unlabeled oligonucleotides can also be used together with labeled oligonucleotides.
- the incubation of samples with unlabelled and labeled oligonucleotides preferably serves to increase the specificity of the probes. For example, it is possible to distinguish closely related species from microorganisms by using an oligonucleotide for an undetectable species that is closely related to a species to be detected, which under the selected conditions hybridizes better with the target sequence of the rRNA of the undetectable microorganism than that marked probe.
- the unlabeled probe hybridizes better with the rRNA of the undetectable microorganism than the labeled probe, binding of the labeled probe to the rRNA of the undetectable microorganism and thus a false positive result is prevented by using the unlabeled oligonucleotide (competitor).
- the specific detection of certain microorganism species or groups of microorganisms is thereby made possible, especially in the presence of closely related species with a very similar rRNA sequence.
- the oligonucleotide according to SEQ ID No. 21 it is suitable according to the invention, together with the oligonucleotide according to SEQ ID No. 21 the oligonucleotide according to SEQ ID No. 22 to use.
- the oligonucleotide according to SEQ ID No. 21 marked and the oligonucleotide according to SEQ ID No. 22 used unmarked.
- the microorganism species, the 16 S rRNA sequence of which is shown under SEQ ID No. 31 specified sequence includes, can be detected easily, without that C. afermentans is detected at the same time (compare analysis result in the example). It can also be suitable according to the invention to use oligonucleotides of SEQ ID No. Use 23 and 24 together.
- oligonucleotide with SEQ ID No. 23 marked as a probe is used to detect C. afermentans, masks the oligonucleotide according to SEQ ID No. 24 the very similar target sequence of the microorganism species, the 16 S rRNA sequence of which is shown under SEQ ID No. 31 specified sequence includes.
- oligonucleotide according to SEQ ID No. 26 as an unlabeled competitor together with the oligonucleotide according to SEQ ID No. 25 are used.
- the oligonucleotide combination of one or more oligonucleotides according to SEQ ID No. 19 to 30 contains one or more further oligonucleotides for the detection of species of the genera Staphylococcus, Veillonella, Malassezia and / or Propionibacterium. Different skin-relevant microorganisms can then advantageously be detected simultaneously or in parallel in a sample, in particular in a single process or method.
- oligonucleotides disclosed herein are particularly suitable, in particular those according to SEQ ID No. 1 to 18.
- the implementation of the method according to the invention comprises the following steps: a) taking a sample b) fixation of the microorganisms contained in the sample taken c) incubation of the fixed microorganisms with at least one oligonucleotide to bring about hybridization d) removal of non-hybridized oligonucleotides and e) detection and, if necessary, quantification of the microorganisms hybridized with the oligonucleotides.
- fixing the microorganisms is understood to mean a treatment with which the microorganism shell is made permeable to oligonucleotides. Ethanol is usually used for fixation. If the cell wall cannot be penetrated by the oligonucleotides using these measures, the person skilled in the art is sufficiently aware of further measures which lead to the same result. These include, for example, methanol, mixtures of alcohols, a low-percentage paraformaldehyde solution or a dilute formaldehyde solution or the like.
- the fixed cells are incubated with, in particular, fluorescence-labeled oligonucleotides for the “hybridization”. After penetration of the cell envelope, these may bind to the target sequence corresponding to the oligonucleotide.
- the bond is to be understood as the formation of hydrogen bonds between complementary pieces of nucleic acid.
- oligonucleotides are used in the process according to the invention with a suitable hybridization solution.
- Such a hybridization solution contains, for example, formamide in a concentration between 0% and 80%, preferably from 0-45%, particularly preferably from 20% to 40% and has, for example, a salt concentration (the salt is preferably NaCl) between 0, 1 mol / l and 1.5 mol / l, preferably between 0.5 and 1.0 mol / l, particularly preferably 0.9 mol / l. Furthermore, it generally contains a detergent (usually SDS) in a concentration between 0.001% and 0.2%, preferably 0.005% to 0.1%, particularly preferably of 0.01%.
- a detergent usually SDS
- the solution contains a suitable buffer substance (eg Tris-HCl, Na citrate, HEPES, PIPES or the like), usually in a concentration between 0.01 mol / l and 0.1 mol / l, preferably in a concentration of 0.01 Mol / I to 0.05 mol / I, particularly preferably from 0.02 mol / I.
- a suitable buffer substance eg Tris-HCl, Na citrate, HEPES, PIPES or the like
- the pH of the hybridization solution is generally between 6.0 and 9.0, preferably between 7.0 and 8.0, particularly preferably around 8.0.
- additives can be used, e.g. fragmented salmon sperm DNA or blocking reagents to prevent nonspecific binding in the hybridization reaction or polyethylene glycol, polyvinylpyrrolidone or dextran sulfate to accelerate the hybridization reaction.
- substances can also be added which stain the DNA of all living and / or organisms contained in the sample (e.g. DAPI, 4 ', 6-diamidino-2-phenylindole dihydrochloride).
- DAPI fragmented salmon sperm DNA
- 4 ', 6-diamidino-2-phenylindole dihydrochloride e.g. DAPI, 4 ', 6-diamidino-2-phenylindole dihydrochloride.
- the concentration of the oligonucleotide in the hybridization solution depends on the type of its labeling and the number of target structures. In order to enable fast and efficient hybridization, the number of oligonucleotides should exceed the number of target structures by several orders of magnitude. However, it should be borne in mind that an excessive amount of fluorescence-labeled oligonucleotides leads to increased background fluorescence.
- the concentration of the oligonucleotides should therefore be in a range between 0.5 - 500 ng / ⁇ l.
- the preferred concentration in the context of the method according to the invention is 1-10 ng of each oligonucleotide used per ⁇ l hybridization solution.
- the volume of the hybridization solution used should be between 8 ⁇ l and 100 ml, in a preferred embodiment of the method according to the invention it is between 10 ⁇ l and 1000 ⁇ l, particularly preferably it is between 20 ⁇ j and 40 ⁇ l.
- the duration of the hybridization is usually between 10 minutes and 12 hours; hybridization is preferably carried out for about 1.5 hours.
- the Hybridization temperature is preferably between 44 ° C and 48 ° C, particularly preferably 46 ° C, the parameter of the hybridization temperature, as well as the concentration of salts and detergents in the hybridization solution depending on the oligonucleotides, in particular their lengths and the degree of complementarity Target sequence can be optimized in the cell to be detected.
- the person skilled in the art is familiar with the relevant calculations here.
- this washing solution can contain 0.001-0.1% of a detergent such as SDS, with a concentration of 0.01% being preferred, as well as Tris-HCl or another suitable buffer substance in a concentration of 0.001-0.1 mol / l , preferably 0.02 mol / I, the pH being in the range from 6.0 to 9.0, preferably around 8.0.
- the detergent may be included but is not essential.
- the washing solution usually also contains NaCl, the concentration depending on the stringency required being from 0.003 mol / l to 0.9 mol / l, preferably from 0.01 mol / l to 0.9 mol / l.
- a NaCl concentration of 0.07 mol / l is particularly preferred.
- NaCl concentrations of 0.05-0.22 mol / l are particularly suitable.
- the washing solution can also contain EDTA, the concentration preferably being 0.005 mol / l.
- the washing solution can also contain suitable amounts of preservatives known to the person skilled in the art.
- the "washing off" of the unbound oligonucleotides is usually carried out at a temperature in the range from 44 ° C. to 52 ° C., preferably from 44 ° C. to 50 ° C. and particularly preferably at 44 ° C. to 48 ° C. for a period of 10- 40 minutes, preferably 15 minutes.
- the final evaluation is possible with a light microscope, epifluorescence microscope, chemiluminometer, fluorometer and others
- the speed of this detection method is a particular advantage. While traditional cultivation takes up to seven days for detection, the result is available within three hours after using the method according to the invention. This enables for the first time an accompanying diagnostic control of the effects and undesirable effects of an applied treatment. It is also advantageous here that the method provided according to the invention makes it possible to detect all of the microorganisms mentioned at the same time, which means a further time advantage, since all steps from sampling to evaluation need only be carried out once.
- Another advantage is the possibility to quantify the detected microorganisms.
- a further advantage is the fact that the oligonucleotides provided according to the invention can now also be used for the first time to detect such microorganisms, for example of the skin microflora, which have not previously been recorded by the traditional detection methods.
- oligonucleotide or the oligonucleotides used a wide variety of groups of microorganisms can be detected.
- Another advantage is the high specificity of the oligonucleotides. Specifically determined genera or groups of microorganisms can be detected as well as highly specific individual species of a genus.
- the sample is obtained in step a) of the method i) from the skin surface, ii) from food, iii) from the environment, in particular from water, soil or air, iv) from waste water or from a biofilm , v) from medical examination material, or vi) from a pharmaceutical or cosmetic product.
- the sample is obtained from the skin surface by detaching microorganisms of the skin flora by means of a detergent solution from the area to be examined.
- a major advantage is, for example, that it is now possible for the first time to simultaneously detect these medically and cosmetically relevant microorganisms of the skin microflora.
- By using different markers for the oligonucleotides all, several or individual groups or species of microorganisms can be detected in parallel and clearly differentiated from one another, as required. It also allows the population relationships of these microorganism groups or species and the interactions between them to be analyzed for the first time. This opens up for the first time the possibility of a clear diagnosis and targeted treatment of medically and / or cosmetically relevant skin problems. It is now possible for the first time to record the effects of medical therapy or cosmetic treatment on the overall microflora of the skin. Possible effects as well as undesirable effects of a treatment can be recognized early and can be strengthened or prevented in the further treatment.
- Another advantage is the possibility to quantify the detected microorganisms. For the first time, insights into the absolute and relative quantitative relationships of the microorganisms mentioned in the skin microflora can be obtained. This enables the success and all effects of this treatment to be checked before, during and after medical or cosmetic treatment. In this context, it is also advantageous that the method according to the invention only detects living microorganisms.
- a detergent solution which is intended to facilitate the detachment of the microorganisms from the skin surface.
- Physiologically acceptable detergents such as. B. Tween or Triton, used in concentrations of about 0.01-1 wt .-%.
- the skin surface is rubbed off with the help of a scraping instrument.
- a scraping instrument There are bars of different thicknesses, for. B. with a diameter of 0.05 to 1.5 cm, made of different materials such as glass, metal or plastic. Spatulas made of the materials mentioned with a rounded surface are also suitable. Glass rods between 0.4 and 0.8 cm in diameter or plastic spatulas are preferred. Mouthpieces from glass pipettes, e.g. B. a 5 ml glass pipette. It has proven to be particularly suitable to rub rougher surfaces over the skin in order to increase the detachment.
- Plastic spatulas with a rough surface are particularly suitable, for example a sampling spatula made of glass fiber reinforced polyamide from Merck (Art. No. 231J2412, double spatula, length 180 mm). Also suitable according to the invention are rubbing with swabs and the sampling by clapping with more viscous media or skin tears with adhesive films (for example commercial household adhesive strips). In these methods, the microorganisms can be obtained from these objects, for example, by washing with an appropriate buffer solution. The further procedure can also be carried out directly on the adhesive strip.
- the method according to the invention is preferably also used for the control of foods.
- the food samples are taken from milk or milk products (yogurt, cheese, quark, butter, buttermilk), drinking water, drinks (lemonades, beer, juices), baked goods or meat products.
- environmental samples can be examined for the presence of microorganisms using the method according to the invention.
- these samples can be taken from air, water or from the ground.
- the method according to the invention can also be used to examine medical samples. It is for the examination of tissue samples, e.g. Biopsy material from the lungs, tumor or inflammatory tissue, from secretions such as sweat, saliva, sperm and discharge from the nose, urethra or vagina as well as for urine or stool samples.
- tissue samples e.g. Biopsy material from the lungs, tumor or inflammatory tissue, from secretions such as sweat, saliva, sperm and discharge from the nose, urethra or vagina as well as for urine or stool samples.
- Another area of application for the present method is the investigation of waste water, eg activated sludge, digested sludge or anaerobic sludge.
- waste water eg activated sludge, digested sludge or anaerobic sludge.
- it is suitable to analyze biofilms in industrial plants, as well as to examine naturally forming biofilms or biofilms that form during wastewater treatment.
- the method according to the invention can also be used to examine pharmaceutical and cosmetic products, for example ointments, creams, tinctures, juices etc., for example for contamination with microorganisms.
- fixation is carried out by i) denaturing reagents, preferably selected from a group consisting of ethanol, acetone and ethanol-acetic acid mixtures, ii) crosslinking reagents, preferably selected from a group consisting of formaldehyde, paraformaldehyde and glutaraldehyde, or iii) as heat fixation
- the microorganisms can be immobilized on a support after being fixed.
- the fixed cells of the microorganisms are permeabilized before step c) of the method according to the invention.
- permeabilization means an enzymatic treatment of the cells. This treatment makes the cell wall of fungi and gram-positive bacteria permeable to the oligonucleotides. Enzymes suitable for this, their suitable concentrations and solvents suitable for these are known to the person skilled in the art. It goes without saying that the method according to the invention is also suitable for analyzing gram-negative bacteria; the enzymatic treatment for permeabilization is then adapted accordingly, and this can then be dispensed with entirely.
- Permeabilization of the cells prior to hybridization has the advantage that the oligonucleotides can penetrate the cells, but the ribosomes and thus the rRNA cannot escape from the cells.
- the great advantage of this whole cell hybridization technique is that the morphology of the bacteria is intact remains and you can detect these intact bacteria in situ, i.e. in their natural environment. As a result, the bacteria can not only be quantified, but also possible associations between different bacterial groups can be demonstrated.
- the permeabilization can very particularly preferably take place by partial degradation by means of cell wall lytic enzymes, preferably selected from a group consisting of lysozyme, lysostaphin, proteinase K, pronase and mutanolysin.
- cell wall lytic enzymes preferably selected from a group consisting of lysozyme, lysostaphin, proteinase K, pronase and mutanolysin.
- an oligonucleotide suitable as a positive control is also provided.
- Such an oligonucleotide is characterized in that it detects as many, optimally all, of the bacteria or eurkaryotes contained in the analyzed sample.
- the oligonucleotide EUB338 (bacteria) or the oligonucleotide EUK (eukaryotes) described by Amann et al. (1990) is suitable.
- Such a positive control can be used to check that the procedure used has been carried out correctly. Above all, however, it allows the determination of a percentage of the specifically detected microorganisms compared to the
- kits for using the method according to the invention are also provided.
- the most important components of this kit are the respective hybridization solutions with the above-described oligonucleotides that are specific to the microorganisms to be detected. It can also contain a corresponding hybridization solution without oligonucleotides and the corresponding washing solution or a concentrate of the corresponding washing solution. It may also contain enzyme solutions, fixing solutions and, if necessary, an embedding solution. If appropriate, hybridization solutions for carrying out a positive control and a negative control in parallel (for example without or with non-hybridizing oligonucleotides) are included. According to a special embodiment, the kit is used for the detection of microorganisms of the skin microflora.
- kits according to the invention can be used to examine samples of both human and animal skin efficiently and also against a high background of other microorganisms.
- a kit which contains several oligonucleotides or oligonucleotide combinations is particularly suitable.
- those oligonucleotides or oligonucleotide combinations which can detect a larger group of the microorganisms to be detected in a kit with one or more oligonucleotides which can only detect one or a few species from this group.
- Oligonucleotides which can also be used especially in combination for the detection of many different species of the genus Corynebacterium, preferably for the detection of skin-relevant species of the genus Corynebacterium, is such an oligonucleotide with a nucleotide sequence according to one of the SEQ. ID No. 7 to 12, in particular 7, 8, 10 and 11, or their combination, in particular the oligonucleotide combination, all of which are SEQ oligonucleotides. ID No. 7, 8, 10 and 11 contains.
- SEQ ID No. 19 to 26 can be added to the kit.
- the plastic cylinder which is open on both sides, is pressed with the undamaged side onto the skin surface to be examined and with 1.5 ml of the detergent solution (a physiological Tween buffer solution, pH 8.0 with 0.523 KH 2 PO 4 g / liter, 16.73 K 2 HP0 4 g / liter, 8.50 NaCI g / liter, 10.00 tween 80 g / liter and 1.00 trypton g / liter).
- the detergent solution a physiological Tween buffer solution, pH 8.0 with 0.523 KH 2 PO 4 g / liter, 16.73 K 2 HP0 4 g / liter, 8.50 NaCI g / liter, 10.00 tween 80 g / liter and 1.00 trypton g / liter.
- the two liquids are combined. Part of the sample from the two combined liquids is used for the subsequent detection using oligonucleotides, another part is used for the control, which is carried out in parallel, by culturing the microorganisms contained in the sample.
- Sterile water e.g. Millipore water
- Millipore water Sterile water
- a volume of absolute ethanol is then added to the sample taken and centrifuged (room temperature, 8,000 rpm, 5 minutes). The supernatant is discarded and the pellet washed in a volume of 1 x PBS solution. Finally, the pellet is resuspended in 1/10 volume of fixative (50% ethanol) and stored at -20 ° C until further use.
- a suitable volume of a suitable enzyme solution is then applied and the sample incubated (room temperature, 15 min). This step may be repeated with another suitable enzyme solution.
- the permeabilization solution is removed with distilled water and the sample is completely dried again (incubation at 46 ° C. to completely dry).
- the cells are then completely dehydrated again by applying the fixing solution (absolute ethanol) and dried again (46 ° C., 3 min or until completely dry).
- hybridization solution with the oligonucleotides specific for the microorganisms to be detected in each case is then applied to the fixed, fully digested and dehydrated cells.
- the slide is then placed in a chamber moistened with hybridization solution (without oligonucleotides) (46 ° C, 90 min).
- the slide is then immersed in a chamber filled with washing solution and incubated (46 ° C., 15 min).
- the slide is then briefly immersed in a chamber filled with distilled water and then air-dried in the lateral position (46 ° C, 30 min or until completely dry).
- the slide is then embedded in a suitable embedding medium. Finally, the sample is analyzed using a fluorescence microscope.
- Microorganism samples were taken from the forehead of a female test subject with combination skin (typified by a beautician and confirmed by sebometer measurements) using the sampling method described above.
- propionibacteria A very high proportion of propionibacteria was found by counting the fluorescence signals and comparing them with the total number of cells (> 90%). A small proportion of staphylococci was found ( ⁇ 10%). No corynebacteria were found.
- a microorganism sample was taken from the skin of another female subject using the sampling method described above.
- the 16 S rRNA gene of a microorganism was isolated from part of the sample. The subsequent sequence determination showed that it is a new sequence, but the microorganism can be assigned to the genus Corynebacterium. This sequence, on the basis of which a corresponding probe (according to SEQ ID No. 21) was developed, which can detect this microorganism, is under SEQ ID No. 31 specified in the sequence listing.
- Another part of the sample was hybridized with the previously described bacteria-specific probe EUB and with a probe mixture (SEQ ID No. 07 to 11) for the detection of the skin-relevant Corynebacteria.
- a high proportion of corynebacteria was determined by counting the fluorescence signals and comparing them with the total number of cells that had been recorded by the bacteria-specific probe (approx. 73%).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003250080A AU2003250080A1 (en) | 2002-07-18 | 2003-07-16 | Oligonucleotides for detecting micro-organisms |
BR0312944-6A BR0312944A (pt) | 2002-07-18 | 2003-07-16 | Oligonucleotìdeos para detecção de microorganismos |
EP03765004A EP1523579A2 (de) | 2002-07-18 | 2003-07-16 | Obligonukleotide zum nachweis von mikroorganismen |
JP2004522470A JP2006500010A (ja) | 2002-07-18 | 2003-07-16 | 微生物検出用オリゴヌクレオチド |
US11/039,026 US20050202477A1 (en) | 2002-07-18 | 2005-01-18 | Oligonucleotides for detecting microorganisms |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10232776.9 | 2002-07-18 | ||
DE2002132776 DE10232776A1 (de) | 2002-07-18 | 2002-07-18 | Oligonukleotide zum Nachweis von Mikroorganismen |
DE10307732.4 | 2003-02-14 | ||
DE2003107732 DE10307732A1 (de) | 2003-02-14 | 2003-02-14 | Oligonukleotide zum Nachweis von Mikroorganismen |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/039,026 Continuation US20050202477A1 (en) | 2002-07-18 | 2005-01-18 | Oligonucleotides for detecting microorganisms |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004009839A2 true WO2004009839A2 (de) | 2004-01-29 |
WO2004009839A3 WO2004009839A3 (de) | 2004-04-08 |
Family
ID=30771717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/007717 WO2004009839A2 (de) | 2002-07-18 | 2003-07-16 | Obligonukleotide zum nachweis von mikroorganismen |
Country Status (8)
Country | Link |
---|---|
US (1) | US20050202477A1 (de) |
EP (1) | EP1523579A2 (de) |
JP (1) | JP2006500010A (de) |
CN (1) | CN1668765A (de) |
AU (1) | AU2003250080A1 (de) |
BR (1) | BR0312944A (de) |
RU (1) | RU2005103822A (de) |
WO (1) | WO2004009839A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004025710A1 (de) * | 2004-05-26 | 2005-12-22 | Eppendorf Ag | Verfahren zur taxonspezifischen Zellidentifizierung und Zellsortierung auf grampositive Bakterien und Vorrichtungen hierfür |
USD1015798S1 (en) | 2019-06-06 | 2024-02-27 | Sharkninja Operating Llc | Food preparation device |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004009843A2 (de) * | 2002-07-18 | 2004-01-29 | Henkel Kommanditgesellschaft Auf Aktien | Nachweis von mikroorganismen |
JP5201818B2 (ja) * | 2006-11-10 | 2013-06-05 | キヤノン株式会社 | プローブセット、プローブ固定担体及び遺伝子検査方法 |
DE102007021387A1 (de) | 2007-05-04 | 2008-11-06 | Eads Deutschland Gmbh | Detektionsvorrichtung zur Detektion von biologischen Mikropartikeln wie Bakterien, Viren, Sporen, Pollen oder biologische Toxine, sowie Detektionsverfahren |
JP2011514159A (ja) * | 2008-02-19 | 2011-05-06 | ジェン−プロウブ インコーポレイテッド | Propionibacteriumacnesの核酸を検出するための組成物および方法 |
US8852886B2 (en) * | 2008-03-26 | 2014-10-07 | Danisco Us Inc. | Host cells and methods of producing disulfide bond containing proteins |
US8481302B2 (en) * | 2008-11-03 | 2013-07-09 | General Electric Company | Total bacteria monitoring system |
JP7081802B2 (ja) * | 2018-06-04 | 2022-06-07 | 日本メナード化粧品株式会社 | 赤ニキビを予測する方法 |
CN109554490B (zh) * | 2018-12-18 | 2020-09-22 | 蚌埠医学院第一附属医院 | 一种与复发性流产相关的微生物及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0786519A2 (de) * | 1996-01-05 | 1997-07-30 | Human Genome Sciences, Inc. | Polynukleotide und Sequenzen aus Staphylococcus aureus |
WO2000075636A1 (en) * | 1999-06-04 | 2000-12-14 | Kairos Scientific, Inc. | Multispectral taxonomic identification |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5426025A (en) * | 1992-05-28 | 1995-06-20 | Florida State University | Species-specific DNA probes for vibrio vulnificus methods and kits |
FR2733755B1 (fr) * | 1995-05-03 | 1997-07-11 | Bio Merieux | Fragment nucleotidique de l'arn ribosomique 16s de corynebacteries, sondes et amorces derivees, reactif et procede de detection |
WO2004009843A2 (de) * | 2002-07-18 | 2004-01-29 | Henkel Kommanditgesellschaft Auf Aktien | Nachweis von mikroorganismen |
-
2003
- 2003-07-16 CN CNA038170558A patent/CN1668765A/zh active Pending
- 2003-07-16 BR BR0312944-6A patent/BR0312944A/pt not_active IP Right Cessation
- 2003-07-16 JP JP2004522470A patent/JP2006500010A/ja not_active Withdrawn
- 2003-07-16 EP EP03765004A patent/EP1523579A2/de not_active Withdrawn
- 2003-07-16 WO PCT/EP2003/007717 patent/WO2004009839A2/de active Application Filing
- 2003-07-16 RU RU2005103822/13A patent/RU2005103822A/ru not_active Application Discontinuation
- 2003-07-16 AU AU2003250080A patent/AU2003250080A1/en not_active Abandoned
-
2005
- 2005-01-18 US US11/039,026 patent/US20050202477A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0786519A2 (de) * | 1996-01-05 | 1997-07-30 | Human Genome Sciences, Inc. | Polynukleotide und Sequenzen aus Staphylococcus aureus |
WO2000075636A1 (en) * | 1999-06-04 | 2000-12-14 | Kairos Scientific, Inc. | Multispectral taxonomic identification |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004025710A1 (de) * | 2004-05-26 | 2005-12-22 | Eppendorf Ag | Verfahren zur taxonspezifischen Zellidentifizierung und Zellsortierung auf grampositive Bakterien und Vorrichtungen hierfür |
USD1015798S1 (en) | 2019-06-06 | 2024-02-27 | Sharkninja Operating Llc | Food preparation device |
Also Published As
Publication number | Publication date |
---|---|
BR0312944A (pt) | 2005-07-12 |
JP2006500010A (ja) | 2006-01-05 |
AU2003250080A1 (en) | 2004-02-09 |
RU2005103822A (ru) | 2005-11-10 |
WO2004009839A3 (de) | 2004-04-08 |
EP1523579A2 (de) | 2005-04-20 |
CN1668765A (zh) | 2005-09-14 |
AU2003250080A8 (en) | 2004-02-09 |
US20050202477A1 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102007041864B4 (de) | Verfahren zum Nachweis von Bakterien und Pilzen | |
DE3486467T3 (de) | Verfahren zum Nachweis, Identifizieren und Quantifizieren von Organismen und Viren | |
DE19732086C2 (de) | Verfahren zur quantitativen Bestimmung von Eubakterien | |
AT503862B1 (de) | Pathogen-identifizierung anhand eines 16s oder 18s-rrna mikroarray | |
WO2001007648A1 (de) | Verfahren zum speziesspezifischen nachweis von organismen | |
US20050202477A1 (en) | Oligonucleotides for detecting microorganisms | |
US20050202476A1 (en) | Detection of microorganisms | |
EP1177319B1 (de) | Verfahren zum nachweisen von mikroorganismen in einer probe | |
EP1522595A2 (de) | Oligonukleotide, Verfahren und System zur Detektion von antibiotikaresistenzvermittelnden Genen in Mikroorganismen mittels der Echtzeit-PCR | |
DE10232775A1 (de) | Nachweis von Mikroorganismen | |
DE10129410A1 (de) | Verfahren zum spezifischen Schnellnachweis bierschädlicher Bakterien | |
DE60025906T2 (de) | Nachweis und quantifizierung von microorganismen anhand amplifizierung und restriktionsenzymeanalyse | |
DE10307732A1 (de) | Oligonukleotide zum Nachweis von Mikroorganismen | |
DE10232776A1 (de) | Oligonukleotide zum Nachweis von Mikroorganismen | |
EP2841596B1 (de) | Nachweisverfahren für mycobacterium avium ssp. paratuberculosis | |
EP1490507B1 (de) | Verfahren zum nachweis von mikroorganismen mittels in situ-hybridisierung und durchflusszytometrie | |
DE10057841B4 (de) | Verfahren zum Nachweis von Protozoen der Gattung Naegleria | |
DE10306616A1 (de) | Kit zum Nachweis von Mikroorganismen | |
WO2002064824A2 (de) | Oligonukleotidsonden zur detektion von parodontopathogenen bakterien mittels in situ-hybridisierung | |
EP1280603B1 (de) | Verfahren zur identifizierung, quantifizierung und visualisierung von mikroorganismen | |
DE19936875C2 (de) | Verfahren zum Nachweisen von Mikroorganismen in einer Probe | |
WO2003066894A2 (de) | Gensonden zum nachweis von spezies der gattung oenococcus | |
AT503401A1 (de) | Microarray zur erkennung von pathogenen | |
WO2002101089A2 (de) | Verfahren zum spezifischen schnellnachweis fadenförmiger bakterien | |
DE102008002978A1 (de) | Verfahren zur Differenzierung von verschiedenen Spezies der Gattung Methylobakterium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR BY CA CN HR ID IL IN IS JP KR LT LV MX NO NZ PL RU SG UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003765004 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038170558 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11039026 Country of ref document: US Ref document number: 2004522470 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 166554 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2005103822 Country of ref document: RU Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2003765004 Country of ref document: EP |